Transfusion‑related immunomodulation in patients with cancer: Focus on the impact of extracellular vesicles from stored red blood cells (Review)

  • Authors:
    • Xingyu Ma
    • Yanxi Liu
    • Qianlan Han
    • Yunwei Han
    • Jing Wang
    • Hongwei Zhang
  • View Affiliations

  • Published online on: November 25, 2021     https://doi.org/10.3892/ijo.2021.5288
  • Article Number: 108
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Red blood cell (RBC) transfusions may have a negative impact on the prognosis of patients with cancer, where transfusion‑related immunomodulation (TRIM) may be a significant contributing factor. A number of components have been indicated to be associated with TRIM. Among these, the impact of extracellular vesicles (EVs) has been garnering increasing attention from researchers. EVs are defined as nano‑scale, cell‑derived vesicles that carry a variety of bioactive molecules, including proteins, nucleic acids and lipids, to mediate cell‑to‑cell communication and exert immunoregulatory functions. RBCs in storage constitutively secrete EVs, which serve an important role in TRIM in patients with cancer receiving a blood transfusion. Therefore, the present review aimed to first summarize the available information on the biogenesis and characterization of EVs. Subsequently, the possible mechanisms of TRIM in patients with cancer and the impact of EVs on TRIM were discussed, aiming to provide an outlook for future studies, specifically for formulating recommendations for managing patients with cancer receiving RBC transfusions.

Related Articles

Journal Cover

December-2021
Volume 59 Issue 6

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Ma X, Liu Y, Han Q, Han Y, Wang J and Zhang H: Transfusion‑related immunomodulation in patients with cancer: Focus on the impact of extracellular vesicles from stored red blood cells (Review). Int J Oncol 59: 108, 2021
APA
Ma, X., Liu, Y., Han, Q., Han, Y., Wang, J., & Zhang, H. (2021). Transfusion‑related immunomodulation in patients with cancer: Focus on the impact of extracellular vesicles from stored red blood cells (Review). International Journal of Oncology, 59, 108. https://doi.org/10.3892/ijo.2021.5288
MLA
Ma, X., Liu, Y., Han, Q., Han, Y., Wang, J., Zhang, H."Transfusion‑related immunomodulation in patients with cancer: Focus on the impact of extracellular vesicles from stored red blood cells (Review)". International Journal of Oncology 59.6 (2021): 108.
Chicago
Ma, X., Liu, Y., Han, Q., Han, Y., Wang, J., Zhang, H."Transfusion‑related immunomodulation in patients with cancer: Focus on the impact of extracellular vesicles from stored red blood cells (Review)". International Journal of Oncology 59, no. 6 (2021): 108. https://doi.org/10.3892/ijo.2021.5288